p18 in stem cell manipulations

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S455000, C435S461000

Reexamination Certificate

active

07863044

ABSTRACT:
A method to increase self-renewal of an undifferentiaded human stem cell culture or cell line, by reducing or eliminating the presence of the protein “p18”.

REFERENCES:
patent: 5837507 (1998-11-01), Largman et al.
patent: 6033847 (2000-03-01), Sherr et al.
Franklin et al, Genes and Development, 1998, vol. 12, No. 18, pp. 2899-2911.
Deans et al, “Mesenchymal Stem Cells: Biology and potential clinical uses” Experimental Hematology, 2000, vol. 28, pp. 875-884.
Nakauchi et al, “Quantitative Assessment of the Stem Cell Self-Renewal Capacity” Annals of the New York Academy of Sciences, 2001, vol. 938, pp. 18-25.
Guan et al, “Growth suppression by p18, a p16(INK4/MTS1) and p14(INK4B/MTS2)-related CDK6 inhibitor, correlates with wild-type pRb function” Genes and Development, 1994, vol. 8, No. 24, pp. 2339-2952.
Cheng, T “Toward ‘SMART’ Stem cells” Gene Therapy, 2008, vol. 15, pp. 67-73.
Bertrand et al, “Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo” Biochemical and Biophysical Research Communications, 2002, vol. 296, pp. 1000-1004.
An et al, “Efficient Lentiviral Vectors for Short Hairpin RNA delivery into Human Cells” Human Gene Therapy, Aug. 2003, vol. 14, pp. 1207-1212.
Walters et al, “The Effectiveness of Double-Stranded Short Inhibitory RNAs (siRNAs) May Depend on the Method of Transfection” Antisense and Nucleic Acid Drug Development, 2002, vol. 12, pp. 411-418.
David S. Franklin, Viriginia L. Godfrey, Hayyoung Lee, Grigoriy I. Kovalev, Robert Schoonhoven, Selina Chen-Kiang, Lishan Su and Yue Xiong,CDK Inhibitors p18INK4cand p27Kip1Mediate Two Separate Pathways To Collaboratively Suppress Pituitary Tumorigenesis, Genes & Development 12, (18) 2899-2911 (1998).
M.P. Tschan, U.R. Peters, J.F. Cajot, D.C. Betticher, M.F. Fey, and A. Tobler,The Cyclin-Dependent Kinase Inhibitors p18INK4cand p19INK4dAre Highly Expressed In CD34+Progenitor and Acute Myeloid Leukaemic Cells But Not In Normal Differentiated Myeloid Cells, British Journal of Haematology, 644-651, (1999).
Shi-Jiang Lu, Chengshi Quan, Fei Li, Loyda Vida and George R. Honig,Hematopoietic Progenitor Cells Derived From Embryonic Stem Cells: Analysis Of Gene Expression, Stem Cells 20, 428-437, (2002).
Youzhong Yuan, Hongmei Shen, David S. Franklin, David T. Scadden and Tao Cheng,In Vivo Self-Renewing Divisions Of Haematopoietic Stem Cells Are Increased In The Absence Of The Early G1-Phase Inhibitor, p18INK4c, Nature Cell Biology, vol. 6, No. 5, 436-442 (2004).
Tao Cheng, et al., Transforming growth factor B1 mediates cell-cycle arrest of primitive hematopoietic cells independent of p21Cip1/Waf1or P27Kip1, Blood, Dec. 15, 2001, vol. 98, No. 13, pp. 3643-3649.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

p18 in stem cell manipulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with p18 in stem cell manipulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and p18 in stem cell manipulations will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2681859

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.